Oscar Health, Inc. (OSCR), Tuesday announced preliminary financial results for the second quarter, expecting a loss from operations of approximately $230 million and a net loss of about $228 million.
Moreover, the company has revised its full year 2025 outlook. It now anticipates total revenue of $12.0 billion to $12.2 billion, and an adjusted EBITDA loss of approximately $120 million less than the loss from operations.
Analysts, on average, estimate revenue of $11.24 billion for the same year.
In the pre-market hours, Oscar's stock is trading at $13.84, up 1.73 percent on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.